RU2013125030A - Способ стимуляции кишечной флоры - Google Patents
Способ стимуляции кишечной флоры Download PDFInfo
- Publication number
- RU2013125030A RU2013125030A RU2013125030/15A RU2013125030A RU2013125030A RU 2013125030 A RU2013125030 A RU 2013125030A RU 2013125030/15 A RU2013125030/15 A RU 2013125030/15A RU 2013125030 A RU2013125030 A RU 2013125030A RU 2013125030 A RU2013125030 A RU 2013125030A
- Authority
- RU
- Russia
- Prior art keywords
- bifidobacterium
- composition
- oligosaccharides
- species
- digestible
- Prior art date
Links
- 230000000968 intestinal effect Effects 0.000 title claims 4
- 238000000034 method Methods 0.000 title claims 2
- 230000004936 stimulating effect Effects 0.000 title 1
- 229920001542 oligosaccharide Polymers 0.000 claims abstract 33
- 239000000203 mixture Substances 0.000 claims abstract 30
- 241000186000 Bifidobacterium Species 0.000 claims abstract 25
- 244000005700 microbiome Species 0.000 claims abstract 17
- 150000002482 oligosaccharides Chemical class 0.000 claims abstract 17
- 241000894007 species Species 0.000 claims abstract 14
- 241000186016 Bifidobacterium bifidum Species 0.000 claims abstract 7
- 229940002008 bifidobacterium bifidum Drugs 0.000 claims abstract 7
- 241000186012 Bifidobacterium breve Species 0.000 claims abstract 5
- 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 claims abstract 5
- 241001134772 Bifidobacterium pseudocatenulatum Species 0.000 claims abstract 5
- 229940004120 bifidobacterium infantis Drugs 0.000 claims abstract 5
- 241001608472 Bifidobacterium longum Species 0.000 claims abstract 4
- 241001034431 Bifidobacterium thermacidophilum Species 0.000 claims abstract 4
- 229920001353 Dextrin Polymers 0.000 claims abstract 4
- 239000004375 Dextrin Substances 0.000 claims abstract 4
- 229940009291 bifidobacterium longum Drugs 0.000 claims abstract 4
- 235000019425 dextrin Nutrition 0.000 claims abstract 4
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims abstract 4
- 150000003271 galactooligosaccharides Chemical class 0.000 claims abstract 4
- 238000004519 manufacturing process Methods 0.000 claims abstract 4
- 241000894006 Bacteria Species 0.000 claims 3
- 241000186014 Bifidobacterium angulatum Species 0.000 claims 3
- 241000186011 Bifidobacterium catenulatum Species 0.000 claims 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims 2
- 150000001720 carbohydrates Chemical class 0.000 claims 2
- 235000014633 carbohydrates Nutrition 0.000 claims 2
- 235000020256 human milk Nutrition 0.000 claims 2
- 210000004251 human milk Anatomy 0.000 claims 2
- 239000007788 liquid Substances 0.000 claims 2
- 235000016709 nutrition Nutrition 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 241000186018 Bifidobacterium adolescentis Species 0.000 claims 1
- 241001134770 Bifidobacterium animalis Species 0.000 claims 1
- 241001312346 Bifidobacterium gallicum Species 0.000 claims 1
- 241001468229 Bifidobacterium thermophilum Species 0.000 claims 1
- 229930091371 Fructose Natural products 0.000 claims 1
- 239000005715 Fructose Substances 0.000 claims 1
- 241000186660 Lactobacillus Species 0.000 claims 1
- 235000008452 baby food Nutrition 0.000 claims 1
- 229940118852 bifidobacterium animalis Drugs 0.000 claims 1
- 229940039696 lactobacillus Drugs 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
- A23C9/203—Dietetic milk products not covered by groups A23C9/12 - A23C9/18 containing bifidus-active substances, e.g. lactulose; containing oligosaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
- A23C9/206—Colostrum; Human milk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/113—Acidophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/125—Casei
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/143—Fermentum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/151—Johnsonii
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/157—Lactis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/165—Paracasei
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/173—Reuteri
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/187—Zeae
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/21—Streptococcus, lactococcus
- A23V2400/249—Thermophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/513—Adolescentes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/515—Animalis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/517—Bifidum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/519—Breve
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/521—Catenulatum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/527—Gallicum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/529—Infantis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/531—Lactis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/533—Longum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/535—Pseudocatenulatum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/537—Thermacidophilum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
- A61K31/708—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/732—Pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/734—Alginic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pediatric Medicine (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Ophthalmology & Optometry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
1. Применение:а) по меньшей мере, двух различных микроорганизмов; илиb) по меньшей мере, одного микроорганизма и, по меньшей мере, одного неусваиваемого олигосахарида; илис) по меньшей мере, двух различных видов Bifidobacteria, подвидов или штаммов для изготовления композиции для энтерального введения грудному ребенку, рожденному с помощью кесарева сечения.2. Применение по п. 1, где композиция содержит, по меньшей мере, один вид Bifidobacteria.3. Применение по п. 1, где композиция включает, по меньшей мере, один вид Bifidobacterium, выбранный из группы, состоящей из Bifidobacterium breve, Bifidobacterium infantis, Bifidobacterium bifidum, Bifidobacterium catenulatum, Bifidobacterium adolescentis, Bifidobacterium thermophilum, Bifidobacterium gallicum, Bifidobacterium animalis, Bifidobacterium angulatum, Bifidobacterium pseudocatenulatum, Bifidobacterium thermacidophilum и Bifidobacterium longum.4. Применение по п. 1, где композиция включает, по меньшей мере, два вида Bifidobacterium, выбранных из группы, состоящей из Bifidobacterium breve, Bifidobacterium infantis, Bifidobacterium bifidum, Bifidobacterium catenulatum, Bifidobacterium adolescentis, Bifidobacterium thermophilum, Bifidobacterium gallicum, Bifidobacterium animalis, Bifidobacterium angulatum, Bifidobacterium pseudocatenulatum, Bifidobacterium thermacidophilum и Bifidobacterium longum.5. Применение по п. 1, где композиция включает, по меньшей мере, один микроорганизм и, по меньшей мере, один неусваиваемый олигосахарид.6. Применение по п. 5, где неусваиваемый олигосахарид, выбран из группы, состоящей из галактоолигосахаридов, неусваиваемых декстринов, ксилоолигосахаридов, арабиноолигосахаридов, глюкоолигосахаридов, манноолигосахаридов, изомальто-олигосахаридов и фруктоолигосахаридов.7. Применение по п. 3, где композиция включает по меньшей мере один микроорганизм и по меньшей мере один неусваиваемый олигосахарид.8. Применение по п. 7, где неусваиваемый олигосахарид выбран из группы, состоящей
Claims (20)
1. Применение:
а) по меньшей мере, двух различных микроорганизмов; или
b) по меньшей мере, одного микроорганизма и, по меньшей мере, одного неусваиваемого олигосахарида; или
с) по меньшей мере, двух различных видов Bifidobacteria, подвидов или штаммов для изготовления композиции для энтерального введения грудному ребенку, рожденному с помощью кесарева сечения.
2. Применение по п. 1, где композиция содержит, по меньшей мере, один вид Bifidobacteria.
3. Применение по п. 1, где композиция включает, по меньшей мере, один вид Bifidobacterium, выбранный из группы, состоящей из Bifidobacterium breve, Bifidobacterium infantis, Bifidobacterium bifidum, Bifidobacterium catenulatum, Bifidobacterium adolescentis, Bifidobacterium thermophilum, Bifidobacterium gallicum, Bifidobacterium animalis, Bifidobacterium angulatum, Bifidobacterium pseudocatenulatum, Bifidobacterium thermacidophilum и Bifidobacterium longum.
4. Применение по п. 1, где композиция включает, по меньшей мере, два вида Bifidobacterium, выбранных из группы, состоящей из Bifidobacterium breve, Bifidobacterium infantis, Bifidobacterium bifidum, Bifidobacterium catenulatum, Bifidobacterium adolescentis, Bifidobacterium thermophilum, Bifidobacterium gallicum, Bifidobacterium animalis, Bifidobacterium angulatum, Bifidobacterium pseudocatenulatum, Bifidobacterium thermacidophilum и Bifidobacterium longum.
5. Применение по п. 1, где композиция включает, по меньшей мере, один микроорганизм и, по меньшей мере, один неусваиваемый олигосахарид.
6. Применение по п. 5, где неусваиваемый олигосахарид, выбран из группы, состоящей из галактоолигосахаридов, неусваиваемых декстринов, ксилоолигосахаридов, арабиноолигосахаридов, глюкоолигосахаридов, манноолигосахаридов, изомальто-олигосахаридов и фруктоолигосахаридов.
7. Применение по п. 3, где композиция включает по меньшей мере один микроорганизм и по меньшей мере один неусваиваемый олигосахарид.
8. Применение по п. 7, где неусваиваемый олигосахарид выбран из группы, состоящей из галактоолигосахаридов, неусваиваемых декстринов, ксилоолигосахаридов, арабиноолигосахаридов, глюкоолигосахаридов, манноолигосахаридов, изомальто-олигосахаридов и фруктоолигосахаридов.
9. Применение по п. 4, где композиция включает по меньшей мере один микроорганизм и по меньшей мере один неусваиваемый олигосахарид.
10. Применение по п. 9, где неусваиваемый олигосахарид выбран из группы состоящей из галактоолигосахаридов, неусваиваемых декстринов, ксилоолигосахаридов, арабиноолигосахаридов, глюкоолигосахаридов, манноолигосахаридов, изомальто-олигосахаридов и фруктоолигосахаридов.
11. Применение по любому из предшествующих пунктов, где композиция включает от 5 до 25 энергетических % белка; от 25 до 60 энергетических % жира; от 30 до 70 энергетических % углеводов.
12. Применение по любому из пп. 1-10, где композицию вводят грудным детям, получающим грудное молоко.
13. Применение по любому из пп. 1-10, где композицию вводят грудным детям в течение одной недели после рождения.
14. Питательная композиция, включающая от 5 до 25 энергетических % белка; от 25 до 60 энергетических % жира; от 30 до 70 энергетических % углеводов; по меньшей мере, два различных вида Bifidobacteria и, по меньшей мере, один вид Lactobacillus.
15. Способ изготовления детского питания, пригодного для грудного ребенка, рожденного с помощью кесарева сечения, включающий смешивание:
а. грудного молока; и
b. композиции, включающей:
i. по меньшей мере, два различных микроорганизма; или
ii. по меньшей мере, один микроорганизм и, по меньшей мере, один неусваиваемый олигосахарид; или
iii. по меньшей мере, два различных вида Bifidobacteria, подвиды или штаммы.
16. Применение композиции, полученной способом, включающим стадии:
а) смешивание:
I) питательно или фармацевтически приемлемой жидкости; и
II) сухой композиции, где сухая композиция II включает, по меньшей мере, два различных микроорганизма или, по меньшей мере, один микроорганизм и, по меньшей мере, один неусваиваемый олигосахарид; или, по меньшей мере, два различных вида
Bifidobacteria, подвиды или штаммы; и
b) введение композиции, полученной на стадии а) грудному ребенку,
для стимуляции развития здоровой кишечной флоры у грудного ребенка, рожденного с помощью кесарева сечения.
17. Применение композиции, содержащей микроорганизмы и неусваиваемые олигосахариды для изготовления композиции, стимулирующей кишечную флору у грудного ребенка, рожденного с помощью кесарева сечения, введением указанной композиции грудному ребенку в течение 100 ч после рождения.
18. Применение композиции, содержащей микроорганизмы и неусваиваемые олигосахариды для изготовления композиции, стимулирующей кишечную флору у грудного ребенка, рожденного с помощью кесарева сечения, ректальным введением указанной композиции грудному ребенку в возрасте меньше 3 лет.
19. Питательная или фармацевтическая композиция, включающая, по меньшей мере, пять видов из вида Bifidobacteria, где, по меньшей мере, четыре вида Bifidobacteria, подвидов и/или штаммов, выбранных из группы, состоящей из Bifidobacterium breve, Bifidobacterium infantis, Bifidobacterium bifidum, Bifidobacterium catenulatum, Bifidobacterium adolescentis, Bifidobacterium thermophilum, Bifidobacterium gallicum, Bifidobacterium animalis, Bifidobacterium angulatum, Bifidobacterium pseudocatenulatum, Bifidobacterium thermacidophilum и Bifidobacterium longum.
20. Контейнер с объемом жидкости от 0,5 до 25 мл, содержащий композицию для введения грудному ребенку, включающую, по меньшей мере, два различных микроорганизма; или, по меньшей мере, один микроорганизм и, по меньшей мере, один неусваиваемый олигосахарид; или по меньшей мере, два различных вида Bifidobacteria, подвиды или штаммы, где композиция включает, по меньшей мере, один вид, выбранный из рода Bifidobacteria.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05023029A EP1776877A1 (en) | 2005-10-21 | 2005-10-21 | Method for stimulating the intestinal flora |
EP05023029.1 | 2005-10-21 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2008115436/15A Division RU2497535C2 (ru) | 2005-10-21 | 2006-10-20 | Способ стимуляции кишечной флоры |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2017142555A Division RU2762984C2 (ru) | 2005-10-21 | 2017-12-06 | Способ стимуляции кишечной флоры |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2013125030A true RU2013125030A (ru) | 2014-12-10 |
RU2639490C2 RU2639490C2 (ru) | 2017-12-21 |
Family
ID=35809614
Family Applications (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2008119992/13A RU2424736C2 (ru) | 2005-10-21 | 2006-10-06 | Композиция для лечения и/или профилактики аллергии, астмы, инфекции и атопического дерматита у детей, рожденных посредством кесарева сечения (варианты) |
RU2008120024/13A RU2437581C2 (ru) | 2005-10-21 | 2006-10-06 | Способ стимуляции целостности кишечного барьера после родов не через естественные родовые пути |
RU2008115436/15A RU2497535C2 (ru) | 2005-10-21 | 2006-10-20 | Способ стимуляции кишечной флоры |
RU2011137129/15A RU2011137129A (ru) | 2005-10-21 | 2011-09-08 | Способ стимуляции целостности кишечного барьера после родов не через естественные родовые пути |
RU2013125030A RU2639490C2 (ru) | 2005-10-21 | 2013-05-29 | Способ стимуляции кишечной флоры |
RU2017142555A RU2762984C2 (ru) | 2005-10-21 | 2017-12-06 | Способ стимуляции кишечной флоры |
Family Applications Before (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2008119992/13A RU2424736C2 (ru) | 2005-10-21 | 2006-10-06 | Композиция для лечения и/или профилактики аллергии, астмы, инфекции и атопического дерматита у детей, рожденных посредством кесарева сечения (варианты) |
RU2008120024/13A RU2437581C2 (ru) | 2005-10-21 | 2006-10-06 | Способ стимуляции целостности кишечного барьера после родов не через естественные родовые пути |
RU2008115436/15A RU2497535C2 (ru) | 2005-10-21 | 2006-10-20 | Способ стимуляции кишечной флоры |
RU2011137129/15A RU2011137129A (ru) | 2005-10-21 | 2011-09-08 | Способ стимуляции целостности кишечного барьера после родов не через естественные родовые пути |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2017142555A RU2762984C2 (ru) | 2005-10-21 | 2017-12-06 | Способ стимуляции кишечной флоры |
Country Status (21)
Country | Link |
---|---|
US (8) | US20090221486A1 (ru) |
EP (11) | EP1776877A1 (ru) |
JP (1) | JP2009512686A (ru) |
CN (9) | CN103816173B (ru) |
AR (4) | AR056145A1 (ru) |
AT (4) | ATE440508T1 (ru) |
AU (3) | AU2006304992A1 (ru) |
BR (3) | BRPI0617645A2 (ru) |
CA (3) | CA2626615C (ru) |
DE (4) | DE602006016150D1 (ru) |
DK (7) | DK1940246T3 (ru) |
ES (8) | ES2350321T3 (ru) |
HU (2) | HUE028348T2 (ru) |
MY (4) | MY145999A (ru) |
NZ (3) | NZ599302A (ru) |
PL (8) | PL1940247T3 (ru) |
PT (8) | PT2105055E (ru) |
RU (6) | RU2424736C2 (ru) |
SG (2) | SG176521A1 (ru) |
TR (1) | TR201808654T4 (ru) |
WO (4) | WO2007046697A1 (ru) |
Families Citing this family (119)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006012536A2 (en) | 2004-07-22 | 2006-02-02 | Ritter Andrew J | Methods and compositions for treating lactose intolerance |
EP1776877A1 (en) * | 2005-10-21 | 2007-04-25 | N.V. Nutricia | Method for stimulating the intestinal flora |
ATE509624T1 (de) | 2005-12-23 | 2011-06-15 | Nutricia Nv | Zusammensetzung enthaltend mehrfach ungesättigte fettsäuren, proteine, mangan und/oder molybden und nukleotide/nukleoside, zur behandlung von demenz |
US20080254166A1 (en) * | 2007-01-25 | 2008-10-16 | Potter Susan M | Food Additives Containing Combinations of Prebiotics and Probiotics |
EP1974743A1 (en) * | 2007-03-28 | 2008-10-01 | Nestec S.A. | Probiotics to Improve Gut Microbiota |
WO2008153377A1 (en) | 2007-06-15 | 2008-12-18 | N.V. Nutricia | Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide |
CA2687639A1 (en) * | 2007-06-25 | 2008-12-31 | Dsm Ip Assets B.V. | Novel prebiotics |
PT2190304E (pt) * | 2007-09-17 | 2012-03-20 | Nutricia Nv | Formulação nutricional com alto teor energético |
EP2200443B2 (en) * | 2007-09-17 | 2021-06-30 | Cornell University | Branched chain fatty acids for prevention or treatment of gastrointestinal disorders |
MX2010003651A (es) | 2007-10-09 | 2010-07-05 | Enzymotec Ltd | Composiciones de lipido para el tratamiento de desordenes gastrointestinales y la promocion del desarrollo y maduracion intestinal. |
WO2009067000A1 (en) * | 2007-11-20 | 2009-05-28 | N.V. Nutricia | Composition with synbiotics |
EP2072052A1 (en) * | 2007-12-17 | 2009-06-24 | Nestec S.A. | Prevention of opportunistic infections in immune-compromised subjects |
EP2229063A1 (en) * | 2007-12-21 | 2010-09-22 | N.V. Nutricia | Use of non-digestible carbohydrates for improving intestinal microbiota |
EP2252370B1 (en) * | 2008-02-08 | 2018-03-14 | N.V. Nutricia | Use of lipid-rich nutrition for the treatment of post-operative ileus |
WO2009102193A1 (en) * | 2008-02-12 | 2009-08-20 | N.V. Nutricia | A composition comprising bifidobacterium infantis and fructo- and galacto-oligosaccharides for the prevention of intestinal discomfort in infants |
SG188887A1 (en) | 2008-03-14 | 2013-04-30 | Nestec Sa | Synbiotic mixture |
EP2143341A1 (en) | 2008-07-08 | 2010-01-13 | Nestec S.A. | Nutritional Composition Containing Oligosaccharide Mixture |
US20110098246A1 (en) * | 2008-06-06 | 2011-04-28 | N.V. Nutricia | Method for preventing corticosteroid usage |
EP2130440A1 (en) | 2008-06-06 | 2009-12-09 | N.V. Nutricia | Inhibiting E. sakazakii growth |
US20110117077A1 (en) * | 2008-06-13 | 2011-05-19 | N.V. Nutricia | Nutritional composition for infants delivered via caesarean section |
WO2009151315A1 (en) * | 2008-06-13 | 2009-12-17 | N.V. Nutricia | Nutritional composition for infants delivered via caesarean section |
WO2010002241A1 (en) * | 2008-06-30 | 2010-01-07 | N.V. Nutricia | Nutritional composition for infants delivered via caesarean section |
EP2147678A1 (en) * | 2008-07-21 | 2010-01-27 | Nestec S.A. | Probiotics to increase IgA secretion in infants born by caesarean section |
SG10201901259RA (en) | 2009-02-24 | 2019-03-28 | Ritter Pharmaceuticals Inc | Prebiotic formulations and methods of use |
CN101861984B (zh) * | 2009-04-16 | 2012-05-23 | 罗晶 | 低聚糖魔芋米及其制备方法 |
BRPI1014304A2 (pt) * | 2009-05-11 | 2016-04-05 | Nestec Sa | bifidobacterium longum ncc2705 (cncm i-2618) e distúrbios imunes |
BR112012000760B8 (pt) | 2009-07-15 | 2022-09-20 | Nutricia Nv | composição nutricional |
ES2904608T3 (es) * | 2009-07-15 | 2022-04-05 | Nutricia Nv | Fucosil lactosa como oligosacárido no digerible idéntico al de la leche materna para tratar y/o prevenir la diarrea vírica |
CA2771283A1 (en) * | 2009-08-13 | 2011-02-17 | Nestec S.A. | Nutritional compositions including exogenous nucleotides |
FR2955774A1 (fr) | 2010-02-02 | 2011-08-05 | Aragan | Preparation destinee a traiter l'exces ponderal et les desordres associes et applications de ladite preparation |
IT1398553B1 (it) * | 2010-03-08 | 2013-03-01 | Probiotical Spa | Composizione comprendente batteri probiotici per il trattamento di patologie associate con le alterazioni del sistema immunitario. |
CA2796936A1 (en) * | 2010-04-26 | 2011-11-10 | Nestec S.A. | Nutritional compositions and methods for weaning from parenteral nutrition to enteral nutrition |
WO2011137249A1 (en) | 2010-04-28 | 2011-11-03 | Ritter Pharmaceuticals, Inc. | Prebiotic formulations and methods of use |
EP3338565A1 (en) * | 2010-06-04 | 2018-06-27 | N.V. Nutricia | Non-digestible oligosaccharides for oral induction of tolerance against dietary proteins |
WO2011150949A1 (en) * | 2010-06-04 | 2011-12-08 | N.V. Nutricia | Non-digestible oligosaccharides for oral induction of tolerance against dietary proteins |
ES2680920T3 (es) | 2010-07-12 | 2018-09-11 | The Regents Of The University Of California | Oligosacáridos de leche bovina |
US9011909B2 (en) | 2010-09-03 | 2015-04-21 | Wisconsin Pharmacal Company, Llc | Prebiotic suppositories |
WO2012044155A1 (en) | 2010-09-28 | 2012-04-05 | N.V. Nutricia | Fat composition for programming immune response |
EP2454948A1 (en) * | 2010-11-23 | 2012-05-23 | Nestec S.A. | Oligosaccharide mixture and food product comprising this mixture, especially infant formula |
CN107890097A (zh) * | 2010-12-06 | 2018-04-10 | N·V·努特里奇亚 | 发酵的婴儿配方物 |
CN103384478B (zh) | 2010-12-29 | 2016-11-23 | 雅培制药有限公司 | 降低婴儿、幼儿或儿童的坏死性小肠结肠炎、腹痛和短肠综合征的发病率的方法 |
CA2822664C (en) | 2010-12-31 | 2021-07-20 | Abbott Laboratories | Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof |
MX356994B (es) | 2010-12-31 | 2018-06-22 | Abbott Lab | Composiciones nutricionales que comprenden los oligosacaridos de leche humana y los nucleotidos y los usos de las mismas para tratar y/o prevenir la infeccion viral enterica. |
CA3205169A1 (en) | 2010-12-31 | 2012-07-05 | Abbott Laboratories | Human milk oligosaccharides for modulating inflammation |
NZ613180A (en) | 2010-12-31 | 2015-02-27 | Abbott Lab | Methods of using human milk oligosaccharides for improving airway respiratory health |
ES2804258T3 (es) | 2010-12-31 | 2021-02-05 | Abbott Lab | Procedimientos para reducir la incidencia de estrés oxidativo usando oligosacáridos de leche humana, vitamina C y agentes antiinflamatorios |
MX355780B (es) | 2010-12-31 | 2018-04-30 | Abbott Lab | Fórmula pediátrica sintética para estimular células nerviosas entéricas en el tracto gastrointestinal. |
CA2822660C (en) * | 2010-12-31 | 2021-09-07 | Abbott Laboratories | Synbiotic combination of probiotic and human milk oligosaccharides |
MY197622A (en) | 2010-12-31 | 2023-06-28 | Abbott Lab | Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides |
WO2012138698A1 (en) * | 2011-04-08 | 2012-10-11 | Ancora Pharmaceuticals Inc. | Synthesis of beta-mannuronic acid oligosaccharides |
GB201112091D0 (en) | 2011-07-14 | 2011-08-31 | Gt Biolog Ltd | Bacterial strains isolated from pigs |
MX368124B (es) | 2011-08-29 | 2019-09-19 | Abbott Lab | Oligosacaridos de leche humana para prevenir lesion y/o promover cicatrizacion del tracto gastrointestinal. |
GB201117313D0 (en) | 2011-10-07 | 2011-11-16 | Gt Biolog Ltd | Bacterium for use in medicine |
EP2836224A4 (en) | 2012-02-29 | 2015-12-16 | Ethicon Endo Surgery Inc | COMPOSITIONS OF BIOZOOSE AND RELATED METHODS |
WO2013187755A1 (en) | 2012-06-14 | 2013-12-19 | N.V. Nutricia | Fermented infant formula with non digestible oligosaccharides |
RU2630905C2 (ru) * | 2012-11-02 | 2017-09-14 | Н.В. Нютрисиа | Комбинация синбиотиков для улучшения мозговой деятельности |
CN103193896B (zh) * | 2013-03-12 | 2015-09-16 | 武汉纤浓生物科技有限公司 | 一种魔芋葡甘低聚糖的制备方法及其所采用的薄膜蒸发器 |
GB201306536D0 (en) | 2013-04-10 | 2013-05-22 | Gt Biolog Ltd | Polypeptide and immune modulation |
US20160074422A1 (en) * | 2013-05-08 | 2016-03-17 | Northeastern University | Mucus strengthening formulations to alter mucus barrier properties |
EP3074020B1 (en) * | 2013-11-15 | 2022-03-30 | Société des Produits Nestlé S.A. | Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children |
CN105722514A (zh) | 2013-11-15 | 2016-06-29 | 雀巢产品技术援助有限公司 | 用于预防或治疗剖腹产婴儿或幼儿的坏死性小肠结肠炎的组合物 |
CN105722515A (zh) | 2013-11-15 | 2016-06-29 | 雀巢产品技术援助有限公司 | 用于预防或治疗有风险婴儿或幼儿的urt感染的组合物 |
JP6448641B2 (ja) * | 2013-11-29 | 2019-01-09 | ガルデルマ・ソシエテ・アノニム | アトピー性皮膚炎の治療及び/又は予防のためのアベルメクチンファミリー又はミルベマイシンファミリーの化合物 |
RU2699981C2 (ru) * | 2014-08-18 | 2019-09-11 | Сосьете Де Продюи Нестле С.А. | Пребиотики для снижения риска развития ожирения в дальнейшей жизни |
RU2694195C2 (ru) * | 2014-09-30 | 2019-07-09 | Нестек С.А. | Питательная композиция для применения при активации формирования и/или регенерации кишечника и/или печени |
SG10202002593SA (en) | 2014-10-24 | 2020-05-28 | Evolve Biosystems Inc | Activated bifidobacteria and methods of use thereof |
WO2016070151A1 (en) | 2014-10-31 | 2016-05-06 | Whole Biome. Inc. | Methods and compositions relating to microbial treatment and diagnosis of disorders |
CZ306548B6 (cs) * | 2014-12-04 | 2017-03-01 | Výzkumný ústav mlékárenský, s.r.o. | Probiotický přípravek sušený se zvlhčujícím efektem pro speciální aplikace |
ME03077B (me) | 2014-12-23 | 2019-01-20 | 4D Pharma Res Ltd | Pirinski polipepтid i imunska modulacija |
SI3065748T1 (en) | 2014-12-23 | 2018-05-31 | 4D Pharma Research Limited | Severe bacteroid tethethioomycron and its use in reducing inflammation |
CN107427054A (zh) * | 2015-03-05 | 2017-12-01 | 雀巢产品技术援助有限公司 | 用于预防或治疗婴儿或幼儿的耳炎或支气管炎的组合物 |
BR112017019468A2 (pt) * | 2015-03-13 | 2018-05-15 | Evolve Biosystems Inc | composições que metabolizam ou sequestram monômeros de açúcar livres e seus usos |
AU2016259871B2 (en) | 2015-05-11 | 2020-04-16 | Mybiotics Pharma Ltd | Systems and methods for growing a biofilm of probiotic bacteria on solid particles for colonization of bacteria in the gut |
WO2016183535A1 (en) * | 2015-05-14 | 2016-11-17 | University Of Puerto Rico | Methods for restoring microbiota of newborns |
KR101589465B1 (ko) * | 2015-05-21 | 2016-02-01 | 주식회사 쎌바이오텍 | 성장 촉진을 위한 비피도박테리움 브레베 cbt br3 균주 및 이를 포함하는 성장촉진용 기능성 식품 조성물 |
KR101589466B1 (ko) * | 2015-05-21 | 2016-02-01 | 주식회사 쎌바이오텍 | 성장 촉진을 위한 비피도박테리움 롱굼 cbt bg7 균주 및 이를 포함하는 성장촉진용 기능성 식품 조성물 |
CN106259952B (zh) * | 2015-06-01 | 2019-01-15 | 内蒙古伊利实业集团股份有限公司 | 含有核苷酸和膳食纤维的1-3岁幼儿配方奶粉及其制备方法 |
MA51639A (fr) | 2015-06-15 | 2020-04-15 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
MA41010B1 (fr) | 2015-06-15 | 2020-01-31 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
MA41060B1 (fr) | 2015-06-15 | 2019-11-29 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
PE20180267A1 (es) | 2015-06-15 | 2018-02-06 | 4D Pharma Res Ltd | Composiciones que comprenden cepas bacterianas |
EP3206700B1 (en) | 2015-06-15 | 2019-06-05 | 4D Pharma Research Limited | Compositions comprising bacterial strains |
AU2016282647A1 (en) * | 2015-06-23 | 2017-11-09 | Société des Produits Nestlé S.A. | Nutritional compositions and infant formulas containing oligofructose for reducing the load of pathogenic bacteria in the guts of infants and young children |
WO2017043962A1 (en) * | 2015-09-11 | 2017-03-16 | N.V. Nutricia | Method for stimulating microbiota health after non-natural birth |
WO2017043963A1 (en) | 2015-09-11 | 2017-03-16 | N.V. Nutricia | Kit of parts for stimulating microbiota health after non-natural birth |
CN105176822B (zh) * | 2015-10-23 | 2019-01-11 | 广州康泽医疗科技有限公司 | 一种人类肠道益生菌的优化分离方法 |
GB201520497D0 (en) | 2015-11-20 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
LT3209310T (lt) | 2015-11-20 | 2018-04-25 | 4D Pharma Research Limited | Kompozicijos, apimančios bakterinius kamienus |
GB201520638D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
GB201520631D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
US11564667B2 (en) | 2015-12-28 | 2023-01-31 | New York University | Device and method of restoring microbiota of newborns |
NZ745678A (en) | 2016-03-04 | 2019-03-29 | 4D Pharma Plc | Compositions comprising bacterial blautia strains for treating visceral hypersensitivity |
GB201612191D0 (en) | 2016-07-13 | 2016-08-24 | 4D Pharma Plc | Compositions comprising bacterial strains |
EP3426269A4 (en) * | 2016-03-11 | 2019-10-16 | Evolve Biosystems Inc. | FOOD COMPOSITIONS FOR DEHUMIDIFICATION |
US11123383B2 (en) | 2016-05-25 | 2021-09-21 | Mybiotics Pharma Ltd. | Composition and methods for microbiota therapy |
SG11201811227QA (en) | 2016-07-01 | 2019-01-30 | Evolve Biosystems Inc | Method for facilitating maturation of the mammalian immune system |
TWI802545B (zh) | 2016-07-13 | 2023-05-21 | 英商4D製藥有限公司 | 包含細菌菌株之組合物 |
WO2018050710A1 (en) * | 2016-09-13 | 2018-03-22 | Nestec S.A. | Fermented nutritional composition for cow's milk protein allergic subjects |
CN106267383A (zh) * | 2016-09-22 | 2017-01-04 | 南昌大学 | 一种用于恢复剖腹产新生儿共生微生物抹布的制备方法 |
GB201621123D0 (en) | 2016-12-12 | 2017-01-25 | 4D Pharma Plc | Compositions comprising bacterial strains |
CN110573164B (zh) * | 2017-03-08 | 2023-09-29 | N·V·努特里奇亚 | 用于减轻鼻上皮炎症的含有不可消化的低聚糖的组合物 |
JP2020520911A (ja) | 2017-05-22 | 2020-07-16 | フォーディー ファーマ リサーチ リミテッド4D Pharma Research Limited | 細菌株を含む組成物 |
TW201907931A (zh) | 2017-05-24 | 2019-03-01 | 英商4D製藥研究有限公司 | 包含細菌菌株之組合物 |
TW201919670A (zh) | 2017-06-14 | 2019-06-01 | 英商4D製藥研究有限公司 | 包含細菌品系之組成物 |
PL3804737T3 (pl) | 2017-06-14 | 2022-09-12 | 4D Pharma Research Limited | Kompozycje zawierające szczepy bakteryjne |
WO2019031961A1 (en) | 2017-08-11 | 2019-02-14 | N.V. Nutricia | OLIGOSACCHARIDE OF HUMAN MILK TO IMPROVE PHYSICAL IMMUNE CONDITION |
JP2020532515A (ja) | 2017-08-30 | 2020-11-12 | ペンデュラム セラピューティクス, インコーポレイテッド | マイクロバイオーム関連障害の処置のための方法および組成物 |
EP3723778A1 (en) * | 2017-12-11 | 2020-10-21 | N.V. Nutricia | Composition for use for treating delayed colonization by bifidobacterium after birth |
EP3782480A4 (en) * | 2018-03-29 | 2022-01-12 | Morinaga Milk Industry Co., Ltd. | NUTRITIONAL COMPOSITION, FOOD/BEVERAGE COMPOSITION USING THE NUTRITIONAL COMPOSITION AND MODIFIED MILK POWDER USING THE NUTRITIONAL COMPOSITION |
WO2019246316A1 (en) * | 2018-06-19 | 2019-12-26 | Evolve Biosystems, Inc. | Novel oligosaccharides for use in prebiotic applications |
RU2729633C2 (ru) * | 2018-07-05 | 2020-08-11 | Общество С Ограниченной Ответственностью "Валента - Интеллект" | Биологически активная пищевая добавка для профилактики воспалительного заболевания кишечника и функциональных кишечных расстройств и способ ее получения |
CN113766923A (zh) * | 2019-03-28 | 2021-12-07 | 迈彼欧提克斯制药有限公司 | 益生菌生物膜组合物及其制备方法 |
US10709744B1 (en) | 2019-03-28 | 2020-07-14 | Mybiotics Pharma Ltd. | Probiotic biofilm suppositories |
CN110882264B (zh) * | 2019-11-13 | 2021-03-26 | 青岛海洋生物医药研究院股份有限公司 | 一种天麻素和甘露糖醛酸寡糖的药物组合物及其用途 |
WO2021197492A1 (zh) * | 2020-04-03 | 2021-10-07 | 内蒙古伊利实业集团股份有限公司 | 可提升生物体对金黄色葡萄球菌感染的抵御能力的母乳低聚糖 |
CN112933104B (zh) * | 2021-02-02 | 2021-12-14 | 陈玉松 | 核苷酸的新用途 |
WO2023118510A1 (en) | 2021-12-22 | 2023-06-29 | N.V. Nutricia | Mix of specific bifidobacterium species and specific non-digestible oligosaccharides |
WO2023216181A1 (en) | 2022-05-12 | 2023-11-16 | N.V. Nutricia | Improving micriobiota of infants born by caesarean section |
EP4299066A1 (en) * | 2022-06-27 | 2024-01-03 | Hipp & Co | Novel bifidobacterium breve strain |
Family Cites Families (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2007350A6 (es) * | 1987-05-29 | 1989-06-16 | Ganadera Union Ind Agro | Productos alimenticios enriquecidos con nucleosidos yno nucleotidos para la nutricion infantil y de adultos, y procedimiento para su preparacion. |
SU1743607A1 (ru) * | 1990-02-05 | 1992-06-30 | 2-й Московский государственный медицинский институт им.Н.И.Пирогова | Способ профилактики дисбактериоза кишечника у новорожденных детей |
US5472952A (en) * | 1993-03-18 | 1995-12-05 | Bristol-Myers Squibb Company | Partially hydrolyzed pectin in nutritional compositions |
IT1288119B1 (it) | 1996-06-28 | 1998-09-10 | Renata Maria Anna Ve Cavaliere | Composizioni dietetiche da utilizzare nell'alimentazione per via enterica |
EP0923382B1 (en) | 1996-08-09 | 2002-05-29 | Mannatech, Inc. | Compositions of plant carbohydrates as dietary supplements |
DE69600525T2 (de) * | 1996-12-23 | 1998-12-10 | Sitia Yomo Spa | Lyophilisierte, lebende Bakerien enthaltende Nahrungszusammensetzung |
CN1099289C (zh) * | 1997-08-01 | 2003-01-22 | 北京东方百信生物技术有限公司 | 改善肠道生态平衡的微生物制剂及其工艺 |
DE19836339B4 (de) | 1998-08-11 | 2011-12-22 | N.V. Nutricia | Kohlenhydratmischung |
FR2782257B1 (fr) | 1998-08-13 | 2000-11-17 | Seb Sa | Joint indexe pour autocuiseur, et autocuiseur equipe d'un tel joint |
NL1010770C2 (nl) | 1998-12-09 | 2000-06-13 | Nutricia Nv | Preparaat dat oligosacchariden en probiotica bevat. |
JP3149403B2 (ja) * | 1999-03-02 | 2001-03-26 | 明治乳業株式会社 | ビフィズス菌によるオリゴ糖利用能改善剤 |
FR2795917B1 (fr) * | 1999-07-06 | 2001-08-31 | Gervais Danone Sa | Procede de preparation d'un produit lacte immunostimulant et ses applications |
DE19958985A1 (de) * | 1999-12-07 | 2001-06-13 | Nutricia Nv | Oligosaccharidmischung |
AU2001233529A1 (en) * | 2000-02-10 | 2001-08-20 | Andrew W. Bruce | Probiotic therapy for newborns |
DE10006989A1 (de) * | 2000-02-16 | 2001-08-23 | Nutricia Nv | Antiadhäsive Kohlenhydratmischung |
US20040143013A1 (en) * | 2000-02-28 | 2004-07-22 | Bristol-Myers Squibb Company | Use of docosahexaenoic acid and arachidonic acid enhancing the growth of preterm infants |
US6495599B2 (en) | 2000-04-13 | 2002-12-17 | Abbott Laboratories | Infant formulas containing long-chain polyunsaturated fatty acids and uses therof |
DE10057976B4 (de) * | 2000-11-22 | 2005-02-03 | Südzucker AG Mannheim/Ochsenfurt | Verfahren zur Herstellung von Pektinhydrolyseprodukten |
US6511696B2 (en) * | 2000-12-13 | 2003-01-28 | Novartis Nutrition Ag | Infant formula with free amino acids and nucleotides |
PL204217B1 (pl) * | 2000-12-27 | 2009-12-31 | Nutricia Nv | Kompozycja odżywcza, dodatek odżywczy oraz zastosowanie oligosacharydów |
FI109602B (fi) * | 2001-01-25 | 2002-09-13 | Valio Oy | Probioottiyhdistelmä |
US7223434B2 (en) | 2001-11-21 | 2007-05-29 | Gerber Products Company | Blended baby foods |
EP1364586A1 (en) | 2002-05-24 | 2003-11-26 | Nestec S.A. | Probiotics and oral tolerance |
AU2003279193A1 (en) | 2002-10-10 | 2004-05-04 | Wyeth | Infant formula containing nucleotides |
PL375071A1 (en) * | 2002-10-11 | 2005-11-14 | Wyeth | Nutritional formulations containing synbiotic substances |
WO2004067013A1 (en) * | 2003-01-24 | 2004-08-12 | Flora Technology Inc. | Compositions and methods for restoring bacterial flora |
US20050180962A1 (en) * | 2003-01-30 | 2005-08-18 | Eyal Raz | Inactivated probiotic bacteria and methods of use thereof |
US20050175759A1 (en) * | 2004-02-09 | 2005-08-11 | Atul Singhal | Newborn infant formulas and feeding methods |
FR2853908B1 (fr) | 2003-04-16 | 2005-06-03 | Gervais Danone Sa | Produit immunomodulateur obtenu a partir d'une culture de bifidobacterium et compositions le contenant |
PL1638416T3 (pl) * | 2003-06-23 | 2013-09-30 | Nestec Sa | Zastosowanie żywnościowego preparatu do optymalizowania działania bariery jelitowej |
PL1638414T3 (pl) * | 2003-06-23 | 2009-12-31 | Nestec Sa | Mleko modyfikowane niemowlęce lub następne |
CN1566329A (zh) * | 2003-07-09 | 2005-01-19 | 喻超 | 一种延长5种双歧杆菌固体发酵物活菌保存期的制剂 |
WO2005051088A2 (en) * | 2003-11-12 | 2005-06-09 | Abbott Laboratories | Iron-containing human milk fortifier with improved antimicrobial properties |
EP1675480B1 (en) | 2003-10-16 | 2018-06-13 | Nestec S.A. | Nutritional composition against side effects of chemotherapy of radiotherapy |
JP4740866B2 (ja) * | 2003-10-24 | 2011-08-03 | ナムローゼ フェンノートシャップ ニュートリシア | 乳児向けシンバイオティック組成物 |
CA2542996C (en) * | 2003-10-24 | 2014-05-27 | N.V. Nutricia | Immunemodulating oligosaccharides |
CN1305383C (zh) * | 2003-11-03 | 2007-03-21 | 东北农业大学 | 一种含有双歧杆菌冻干粉的奶粉制品及其制备方法 |
EP1597978A1 (en) | 2004-05-17 | 2005-11-23 | Nutricia N.V. | Synergism of GOS and polyfructose |
US8252769B2 (en) * | 2004-06-22 | 2012-08-28 | N. V. Nutricia | Intestinal barrier integrity |
US7862808B2 (en) * | 2004-07-01 | 2011-01-04 | Mead Johnson Nutrition Company | Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12 |
EP1634599A1 (en) | 2004-08-20 | 2006-03-15 | N.V. Nutricia | Iimmune stimulatory infant nutrition |
ES2286558T5 (es) * | 2004-08-24 | 2013-10-15 | N.V. Nutricia | Composición nutritiva que comprende transgalactooligosacáridos indigeribles y sacáridos de galactosa digeribles |
US8591981B2 (en) * | 2005-02-21 | 2013-11-26 | Nestec S.A. | Oligosaccharide mixture |
WO2006091103A2 (en) | 2005-02-28 | 2006-08-31 | N.V. Nutricia | Nutritional composition with probiotics |
BRPI0608782A2 (pt) | 2005-04-13 | 2010-01-26 | Nestec Sa | fórmula para bebê com probióticos |
US7303745B2 (en) * | 2005-04-15 | 2007-12-04 | Bristol-Myers Squibb Company | Method for preventing or treating the development of respiratory allergies |
EP1714660A1 (en) * | 2005-04-21 | 2006-10-25 | N.V. Nutricia | Uronic acid and probiotics |
ES2484798T5 (es) * | 2005-04-27 | 2022-08-16 | Nutricia Nv | Alimentación con lípidos y sacáridos no digeribles |
EP1776877A1 (en) | 2005-10-21 | 2007-04-25 | N.V. Nutricia | Method for stimulating the intestinal flora |
WO2010002241A1 (en) * | 2008-06-30 | 2010-01-07 | N.V. Nutricia | Nutritional composition for infants delivered via caesarean section |
-
2005
- 2005-10-21 EP EP05023029A patent/EP1776877A1/en not_active Withdrawn
-
2006
- 2006-10-06 PT PT91616748T patent/PT2105055E/pt unknown
- 2006-10-06 WO PCT/NL2006/050246 patent/WO2007046697A1/en active Application Filing
- 2006-10-06 AT AT06799536T patent/ATE440508T1/de not_active IP Right Cessation
- 2006-10-06 PL PL06799538T patent/PL1940247T3/pl unknown
- 2006-10-06 PL PL11178047T patent/PL2407036T3/pl unknown
- 2006-10-06 NZ NZ599302A patent/NZ599302A/xx unknown
- 2006-10-06 PT PT06799538T patent/PT1940247E/pt unknown
- 2006-10-06 CN CN201310722592.3A patent/CN103816173B/zh active Active
- 2006-10-06 CN CN200680047835.6A patent/CN101360429B/zh not_active Expired - Fee Related
- 2006-10-06 DK DK06799537.3T patent/DK1940246T3/da active
- 2006-10-06 DE DE602006016150T patent/DE602006016150D1/de active Active
- 2006-10-06 EP EP11178047.4A patent/EP2407036B1/en not_active Revoked
- 2006-10-06 RU RU2008119992/13A patent/RU2424736C2/ru active
- 2006-10-06 BR BRPI0617645-3A patent/BRPI0617645A2/pt not_active Application Discontinuation
- 2006-10-06 US US12/091,050 patent/US20090221486A1/en not_active Abandoned
- 2006-10-06 PT PT111780474T patent/PT2407036E/pt unknown
- 2006-10-06 NZ NZ567579A patent/NZ567579A/en unknown
- 2006-10-06 MY MYPI20081206A patent/MY145999A/en unknown
- 2006-10-06 DK DK09161674.8T patent/DK2105055T3/da active
- 2006-10-06 WO PCT/NL2006/050247 patent/WO2007046698A1/en active Application Filing
- 2006-10-06 EP EP06799537A patent/EP1940246B1/en not_active Revoked
- 2006-10-06 ES ES06799537T patent/ES2350321T3/es active Active
- 2006-10-06 JP JP2008536530A patent/JP2009512686A/ja active Pending
- 2006-10-06 AT AT06799537T patent/ATE476877T1/de active
- 2006-10-06 BR BRPI0617653A patent/BRPI0617653C1/pt not_active IP Right Cessation
- 2006-10-06 US US12/091,047 patent/US20090263537A1/en not_active Abandoned
- 2006-10-06 US US12/091,011 patent/US8715769B2/en active Active
- 2006-10-06 EP EP09161674.8A patent/EP2105055B1/en not_active Revoked
- 2006-10-06 PL PL09161674T patent/PL2105055T3/pl unknown
- 2006-10-06 NZ NZ616421A patent/NZ616421A/en unknown
- 2006-10-06 DK DK11178047.4T patent/DK2407036T3/en active
- 2006-10-06 DE DE602006007161T patent/DE602006007161D1/de active Active
- 2006-10-06 SG SG2011087186A patent/SG176521A1/en unknown
- 2006-10-06 WO PCT/NL2006/050248 patent/WO2007046699A2/en active Application Filing
- 2006-10-06 DK DK06799538T patent/DK1940247T3/da active
- 2006-10-06 ES ES11178047.4T patent/ES2560291T3/es active Active
- 2006-10-06 ES ES09161674.8T patent/ES2460590T3/es active Active
- 2006-10-06 PT PT06799537T patent/PT1940246E/pt unknown
- 2006-10-06 EP EP15181073.6A patent/EP2984943A1/en not_active Withdrawn
- 2006-10-06 CN CN201210414761.2A patent/CN102919663B/zh active Active
- 2006-10-06 MY MYPI20081205A patent/MY146454A/en unknown
- 2006-10-06 CN CNA2006800473329A patent/CN101330837A/zh active Pending
- 2006-10-06 SG SG10201503970XA patent/SG10201503970XA/en unknown
- 2006-10-06 CA CA2626615A patent/CA2626615C/en active Active
- 2006-10-06 HU HUE11178047A patent/HUE028348T2/en unknown
- 2006-10-06 PT PT06799536T patent/PT1940245E/pt unknown
- 2006-10-06 EP EP06799536A patent/EP1940245B1/en not_active Not-in-force
- 2006-10-06 EP EP06799538A patent/EP1940247B1/en not_active Revoked
- 2006-10-06 CA CA2626636A patent/CA2626636C/en not_active Expired - Fee Related
- 2006-10-06 AU AU2006304992A patent/AU2006304992A1/en not_active Abandoned
- 2006-10-06 DE DE602006008817T patent/DE602006008817D1/de active Active
- 2006-10-06 CN CN200680047651XA patent/CN101330838B/zh active Active
- 2006-10-06 RU RU2008120024/13A patent/RU2437581C2/ru not_active IP Right Cessation
- 2006-10-06 ES ES06799538T patent/ES2327781T3/es active Active
- 2006-10-06 AT AT06799538T patent/ATE432620T1/de active
- 2006-10-06 AU AU2006304993A patent/AU2006304993A1/en not_active Abandoned
- 2006-10-06 PL PL06799537T patent/PL1940246T3/pl unknown
- 2006-10-20 DK DK06806443T patent/DK1940250T3/da active
- 2006-10-20 PT PT90111972T patent/PT2140771E/pt unknown
- 2006-10-20 DE DE602006009287T patent/DE602006009287D1/de active Active
- 2006-10-20 WO PCT/EP2006/010159 patent/WO2007045502A1/en active Application Filing
- 2006-10-20 AR ARP060104593A patent/AR056145A1/es unknown
- 2006-10-20 AR ARP060104605A patent/AR058132A1/es unknown
- 2006-10-20 MY MYPI20081180A patent/MY145311A/en unknown
- 2006-10-20 ES ES17205437T patent/ES2857732T3/es active Active
- 2006-10-20 AR ARP060104606A patent/AR058133A1/es not_active Application Discontinuation
- 2006-10-20 PL PL13171226T patent/PL2638812T3/pl unknown
- 2006-10-20 CN CNA2006800354743A patent/CN101272701A/zh active Pending
- 2006-10-20 PT PT06806443T patent/PT1940250E/pt unknown
- 2006-10-20 PT PT131712267T patent/PT2638812T/pt unknown
- 2006-10-20 US US12/083,612 patent/US20090162323A1/en not_active Abandoned
- 2006-10-20 CN CN201510170125.3A patent/CN104814442A/zh active Pending
- 2006-10-20 CN CN201510171216.9A patent/CN105124565A/zh active Pending
- 2006-10-20 PL PL09011197T patent/PL2140771T3/pl unknown
- 2006-10-20 EP EP06806443A patent/EP1940250B1/en not_active Revoked
- 2006-10-20 CN CN201310148476.5A patent/CN103230005B/zh active Active
- 2006-10-20 ES ES09011197.2T patent/ES2451020T3/es active Active
- 2006-10-20 AU AU2006303477A patent/AU2006303477A1/en not_active Abandoned
- 2006-10-20 EP EP17205437.1A patent/EP3326634B1/en active Active
- 2006-10-20 CA CA2620821A patent/CA2620821C/en active Active
- 2006-10-20 DK DK09011197.2T patent/DK2140771T3/en active
- 2006-10-20 PL PL17205437T patent/PL3326634T3/pl unknown
- 2006-10-20 DK DK13171226.7T patent/DK2638812T3/en active
- 2006-10-20 AT AT06806443T patent/ATE442786T1/de active
- 2006-10-20 PL PL06806443T patent/PL1940250T3/pl unknown
- 2006-10-20 BR BRPI0617507-4A patent/BRPI0617507A2/pt not_active Application Discontinuation
- 2006-10-20 AR ARP060104611A patent/AR058136A1/es unknown
- 2006-10-20 ES ES13171226.7T patent/ES2671914T3/es active Active
- 2006-10-20 EP EP09011197.2A patent/EP2140771B1/en not_active Revoked
- 2006-10-20 HU HUE13171226A patent/HUE037858T2/hu unknown
- 2006-10-20 TR TR2018/08654T patent/TR201808654T4/tr unknown
- 2006-10-20 RU RU2008115436/15A patent/RU2497535C2/ru active
- 2006-10-20 EP EP13171226.7A patent/EP2638812B1/en active Active
- 2006-10-20 ES ES06806443T patent/ES2332064T3/es active Active
-
2008
- 2008-04-18 MY MYPI2012001490A patent/MY169058A/en unknown
-
2011
- 2011-09-08 RU RU2011137129/15A patent/RU2011137129A/ru unknown
-
2013
- 2013-05-29 RU RU2013125030A patent/RU2639490C2/ru active
- 2013-12-19 US US14/135,171 patent/US9107438B2/en active Active
-
2015
- 2015-07-30 US US14/813,845 patent/US9585416B2/en active Active
- 2015-09-04 US US14/846,120 patent/US20160058806A1/en not_active Abandoned
- 2015-12-17 US US14/973,166 patent/US9596876B2/en active Active
-
2017
- 2017-12-06 RU RU2017142555A patent/RU2762984C2/ru active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2013125030A (ru) | Способ стимуляции кишечной флоры | |
ES2772685T3 (es) | Composiciones nutricionales con 2FL y LNNT para inducir una microbiota intestinal similar a la de los bebés lactantes | |
ES2725464T3 (es) | Sistema de fórmula infantil con niveles adaptativos de oligosacáridos de leche humana (OLH) | |
RU2448720C2 (ru) | Синбиотическая смесь | |
CN103763940B (zh) | 促进有益微生物群生长的益生菌和人乳寡糖的合益素组合 | |
RU2697650C1 (ru) | Композиции для профилактики или лечения аллергий у младенцев, рожденных или вскармливаемых матерями несекреторного типа, путем обеспечения фукозилированными олигосахаридами, в частности среди младенцев, подверженных риску или рожденных с помощью кесарева сечения | |
RU2586928C2 (ru) | Модуляция роста бифидобактерий в сочетании с олигосахаридами, находящимися в материнском молоке | |
PT2315595E (pt) | Probióticos para aumentar a secreção de iga em lactentes nascidos por cesariana | |
RU2720933C2 (ru) | Композиция, содержащая fut2-зависимые олигосахариды и лакто-n-неотетраозу, для применения с целью активации развития головного мозга и познавательной способности | |
BRPI0809626A2 (pt) | Pró-bióticos para redução de episódios de diarreia em bebês nascidos através de secção cesariana | |
CN113226062A (zh) | 包含2’-岩藻糖基乳糖(2’fl)以改善胃肠屏障的营养组合物 | |
MX2010012905A (es) | Probioticos para mejorar la microbiota intestinal. | |
CN107019701A (zh) | 使用人乳低聚糖来降低婴儿、幼儿或儿童的坏死性小肠结肠炎的发病率的方法 | |
CN102325458A (zh) | 预防及治疗轮状病毒腹泻 | |
CN106659226A (zh) | 用于降低以后生命中肥胖风险的益生元 | |
ES2734204T3 (es) | Lactobacillus salivarius para el tratamiento de la mastitis | |
ES2683190T3 (es) | Probiótico para el llanto infantil excesivo | |
CN109890222A (zh) | 包含人乳低聚糖的个性化儿科营养产品 | |
CN109561723A (zh) | 用于预防、治疗非轮状病毒相关性腹泻或降低其严重程度的包含低聚糖和任选地乳双歧杆菌的混合物的营养组合物和婴儿配方食品 | |
CN108882740A (zh) | 含有不可消化寡糖的发酵配方物 | |
CN112273657A (zh) | 用于预防或改善过敏性疾病的益生菌组合物、制法和应用 | |
CN115068591A (zh) | 一种包含骨桥蛋白的益生菌组合物 | |
JP2015030688A (ja) | 栄養組成物 | |
RU2819186C2 (ru) | Питательная композиция, содержащая 2'-фукозиллактозу (2'fl), для улучшения барьера желудочно-кишечного тракта | |
CN113015440B (zh) | 包含尿素和不可消化寡糖的营养组合物 |